Skip to main content

Table 8 Medical costs during baseline and post-acute phasesa in the overall population and by ageb

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

Cost Description

All Patients (N = 19,558)

Patients Aged 18–64 Years (n = 9381)

Patients Aged ≥ 65 Years (n = 10,177)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Inpatient visits

 Total cost

100,310,406

148,478,802

48,168,396 (48.0)

33,383,596

46,783,646

13,400,051 (40.1)

66,926,810

101,695,155

34,768,345 (52.0)

 Standard costs, patient n

2523

2877

 

884

878

 

1639

1999

 

  Mean ± SD

39,758 ± 53,027

51,609 ± 67,633

11,851 (29.8)

37,764 ± 45,741

53,284 ± 75,612

15,520 (41.1)

40,834 ± 56,553

50,873 ± 63,821

10,039 (24.6)

  Median (Q1; Q3)

23,539 (14,930; 42,393)

29,812 (14,174; 63,142)

6273 (26.6)

21,110 (13,853; 39,804)

28,505 (13,705; 62,482)

7395 (35.0)

24,902 (15,564; 44,262)

30,535 (14,450; 63,458)

5634 (22.6)

 Nonzero costs, patient n

2519

2857

338 (13.4)

882

874

–8 (–0.9)

1637

1983

346 (21.1)

  Mean ± SD

39,822 ± 53,046

51,970 ± 67,731

12,149 (30.5)

37,850 ± 45,757

53,528 ± 75,699

15,678 (41.4)

40,884 ± 56,570

51,283 ± 63,914

10,400 (25.4)

  Median (Q1; Q3)

23,619 (14,979; 42,401)

30,001 (14,418; 63,458)

6381 (27.0)

21,165 (13,872; 39,837)

28,663 (13,872; 62,649)

7498 (35.4)

24,951 (15,604; 44,262)

30,996 (14,591; 63,718)

6045 (24.2)

Readmission

 Total cost

15,508,222

56,595,103

41,086,881 (264.9)

5,968,848

15,288,400

9,319,552 (156.1)

9,539,374

41,306,702

31,767,328 (333.0)

 Standard costs, patient n

327

1145

 

131

220

 

196

925

 

  Mean ± SD

47,426 ± 55,733

49,428 ± 72,129

2002 (4.2)

45,564 ± 43,757

69,493 ± 99,048

23,929 (52.5)

48,670 ± 62,550

44,656 ± 63,226

–4014 (–8.3)

  Median (Q1; Q3)

28,400 (16,155; 57,798)

22,978 (8525; 60,113)

–5422 (–19.1)

29,053 (16,565; 64,883)

37,735 (13,202; 84,318)

8681 (29.9)

28,348 (16,134; 56,708)

21,351 (7368; 56,103)

–6998 (–24.7)

 Nonzero costs, patient n

327

1124

797 (243.7)

131

218

87 (66.4)

196

906

710 (362.2)

  Mean ± SD

47,426 ± 55,733

50,352 ± 72,480

2926 (6.2)

45,564 ± 43,757

70,130 ± 99,277

24,567 (53.9)

48,670 ± 62,550

45,592 ± 63,551

–3078 (–6.3)

  Median (Q1; Q3)

28,400 (16,155; 57,798)

23,734 (10,067; 62,107)

–4665 (–16.4)

29,053 (16,565; 64,883)

37,895 (13,937; 85,396)

8842 (30.4)

28,348 (16,134; 56,708)

22,147 (8769; 57,039)

–6201 (–21.9)

Outpatient visits

 Total cost

252,738,072

293,241,964

40,503,891 (16.0)

101,032,115

111,061,227

10,029,113 (9.9)

151,705,958

182,180,736

30,474,779 (20.1)

 Standard costs, patient n

19,413

19,223

 

9357

9173

 

10,056

10,050

 

  Mean ± SD

13,019 ± 50,071

15,255 ± 50,870

2236 (17.2)

10,797 ± 44,453

12,107 ± 42,523

1310 (12.1)

15,086 ± 54,704

18,127 ± 57,291

3041 (20.2)

  Median (Q1; Q3)

4516 (1746; 11,434)

5284 (1981; 13,581)

768 (17.0)

3363 (1302; 8746)

3781 (1398; 9813)

418 (12.4)

5899 (2369; 13,841)

7071 (2792; 16,649)

1172 (19.9)

 Nonzero costs, patient n

19,412

19,222

–190 (–1.0)

9357

9173

–184 (–2.0)

10,055

10,049

–6 (–0.1)

  Mean ± SD

13,020 ± 50,072

15,256 ± 50,871

2236 (17.2)

10,797 ± 44,453

12,107 ± 42,523

1310 (12.1)

15,088 ± 54,707

18,129 ± 57,293

3042 (20.2)

  Median (Q1; Q3)

4516 (1746; 11,435)

5284 (1981; 13,581)

768 (17.0)

3363 (1302; 8746)

3781 (1398; 9813)

418 (12.4)

5901 (2369; 13,844)

7071 (2792; 16,649)

1170 (19.8)

Emergency department visits

 Total cost

20,718,445

16,776,569

–3,941,876 (–19.0)

10,216,455

8,135,400

–2,081,054 (–20.4)

10,501,990

8,641,168

–1,860,822 (–17.7)

 Standard costs, patient n

5943

4756

 

2830

2149

 

3113

2607

 

  Mean ± SD

3486 ± 5082

3527 ± 6118

41 (1.2)

3610 ± 6055

3786 ± 7975

176 (4.9)

3374 ± 3993

3315 ± 3972

–59 (–1.8)

  Median (Q1; Q3)

2322 (1358; 3981)

2344 (1328; 3971)

22 (0.9)

2265 (1268; 3930)

2385 (1293; 4001)

121 (5.3)

2344 (1484; 4006)

2319 (1360; 3918)

–25 (–1.1)

 Nonzero costs, patient n

5935

4752

–1183 (–19.9)

2828

2149

–679 (–24.0)

3107

2603

–504 (–16.2)

  Mean ± SD

3491 ± 5083

3530 ± 6120

40 (1.1)

3613 ± 6057

3786 ± 7975

173 (4.8)

3380 ± 3994

3320 ± 3973

–60 (–1.8)

  Median (Q1; Q3)

2322 (1362; 3983)

2346 (1332; 3973)

24 (1.0)

2267 (1270; 3932)

2385 (1293; 4001)

118 (5.2)

2352 (1486; 4009)

2322 (1368; 3919)

–30 (–1.3)

Prescription claims

 Total cost

73,381,260

82,891,287

9,510,027 (13.0)

34,332,199

39,019,983

4,687,784 (13.7)

39,049,062

43,871,304

4,822,243 (12.4)

 Standard costs, patient n

17,845

17,824

 

8832

8604

 

9013

9220

 

  Mean ± SD

4112 ± 15,111

4651 ± 16,138

538 (13.1)

3887 ± 14,812

4535 ± 16,441

648 (16.7)

4333 ± 15,396

4758 ± 15,851

426 (9.8)

  Median (Q1; Q3)

652 (183; 2888)

722 (198; 3598)

70 (10.8)

399 (108; 2052)

458 (116; 2631)

59 (14.7)

942 (316; 3624)

1004 (327; 4345)

62 (6.5)

 Nonzero costs, patient n

17,845

17,824

–21 (–0.1)

8832

8604

–228 (–2.6)

9013

9220

207 (2.3)

  Mean ± SD

4112 ± 15,111

4651 ± 16,138

538 (13.1)

3887 ± 14,812

4535 ± 16,441

648 (16.7)

4333 ± 15,396

4758 ± 15,851

426 (9.8)

  Median (Q1; Q3)

652 (183; 2888)

722 (198; 3598)

70 (10.8)

399 (108; 2052)

458 (116; 2631)

59 (14.7)

942 (316; 3624)

1004 (327; 4345)

62 (6.5)

All medical costs (outpatient, inpatient, and prescription claims)

 Total cost

426,429,738

524,612,052

98,182,314 (23.0)

168,747,909

196,864,856

28,116,948 (16.7)

257,681,830

327,747,196

70,065,366 (27.2)

 Standard costs, patient n

19,492

19,375

 

9381

9264

 

10,111

10,111

 

  Mean ± SD

21,877 ± 61,388

27,077 ± 68,249

5200 (23.8)

17,988 ± 54,361

21,251 ± 59,851

3262 (18.1)

25,485 ± 67,055

32,415 ± 74,730

6930 (27.2)

  Median (Q1; Q3)

7025 (2579; 19,791)

8045 (2842; 23,394)

1020 (14.5)

5093 (1898; 15,184)

5597 (1934; 17,259)

504 (9.9)

9137 (3605; 24,705)

10,803 (4238; 29,450)

1666 (18.2)

 Nonzero costs, patient n

19,492

19,373

–119 (–0.6)

9381

9264

–117 (–1.3)

10,111

10,109

–2 (–0.02)

  Mean ± SD

21,877 ± 61,388

27,077 ± 68,249

5200 (23.8)

17,988 ± 54,361

21,251 ± 59,851

3262 (18.1)

25,485 ± 67,055

32,415 ± 74,730

6930 (27.2)

  Median (Q1; Q3)

7025 (2579; 19,791)

8045 (2842; 23,394)

1020 (14.5)

5093 (1898; 15,184)

5597 (1934; 17,259)

504 (9.9)

9137 (3605; 24,705)

10,803 (4238; 29,450)

1666 (18.2)

  1. Standard cost patient n’s (used to calculate standard mean and median) reflect the number of patients who had any healthcare encounter for the specified outcome (eg, all patients with ≥ 1 outpatient visit during the specified time frame). Nonzero cost patient n’s (used to calculate nonzero mean and median) reflect the number of patients who had any costs associated with the specified outcome (eg, all patients with costs > 0 attributable to outpatient visits)
  2. aThe baseline phase was the 12 months before the index date, and the post-acute phase spanned from 1 to 13 months after the index date
  3. bAll costs are in US dollars rounded to the nearest dollar